April 01, 2026

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

Conexiant

April 01, 2026

Evolocumab Reduced CV Events in Diabetes

Subgroup analysis of the VESALIUS-CV trial supports earlier intensive lipid lowering

Conexiant

April 01, 2026

Tirzepatide Linked to Lower Cardiorenal Events

Researchers evaluate expanded six-component outcome in high-risk patients with diabetes

Conexiant

April 01, 2026

BMI Patterns in ILD Outcomes Examined

Meta-analysis links higher body mass index to lower mortality and slower lung function decline in interstitial lung disease

Conexiant

April 01, 2026

Prednisolone Linked to Metabolic Benefits

A randomized crossover trial found slower bone turnover and no safety differences compared with standard hydrocortisone regimens

Conexiant

March 31, 2026

Meat Intake, APOE Status Linked to Cognitive Aging

Long-term cohort data suggest genotype-specific associations with cognition, not dementia interaction

Conexiant

March 31, 2026

AHA Updates Heart-Healthy Dietary Guidance

Nine evidence-based features now frame cardiovascular risk reduction across the life course, with sharper language on alcohol, ultraprocessed foods, and plant protein

Conexiant

March 30, 2026

Tirzepatide Linked to Greater QoL Gains vs Dulaglutide

Both groups improved, with numerically larger gains in patient-reported outcomes following a switch to tirzepatide

Conexiant

March 30, 2026

Knee OA Pain: Inulin vs Physiotherapy Effects

Prebiotic supplementation and physiotherapy show distinct and complementary effects on functional and pain sensitivity outcomes.

Conexiant

March 27, 2026

Hydration Intervention Did Not Reduce Stone Recurrence

A behavioral strategy modestly increased urine volume but did not lower symptomatic events over 2 years.

Conexiant